Style | Citing Format |
---|---|
MLA | Khodarahmi M, et al.. "Interplay Between Fatty Acid Desaturase2 (Fads2) Rs174583 Genetic Variant and Dietary Antioxidant Capacity: Cardio-Metabolic Risk Factors in Obese Individuals." BMC Endocrine Disorders, vol. 22, no. 1, 2022, pp. -. |
APA | Khodarahmi M, Javidzade P, Farhangi MA, Hashemzehi A, Kahroba H (2022). Interplay Between Fatty Acid Desaturase2 (Fads2) Rs174583 Genetic Variant and Dietary Antioxidant Capacity: Cardio-Metabolic Risk Factors in Obese Individuals. BMC Endocrine Disorders, 22(1), -. |
Chicago | Khodarahmi M, Javidzade P, Farhangi MA, Hashemzehi A, Kahroba H. "Interplay Between Fatty Acid Desaturase2 (Fads2) Rs174583 Genetic Variant and Dietary Antioxidant Capacity: Cardio-Metabolic Risk Factors in Obese Individuals." BMC Endocrine Disorders 22, no. 1 (2022): -. |
Harvard | Khodarahmi M et al. (2022) 'Interplay Between Fatty Acid Desaturase2 (Fads2) Rs174583 Genetic Variant and Dietary Antioxidant Capacity: Cardio-Metabolic Risk Factors in Obese Individuals', BMC Endocrine Disorders, 22(1), pp. -. |
Vancouver | Khodarahmi M, Javidzade P, Farhangi MA, Hashemzehi A, Kahroba H. Interplay Between Fatty Acid Desaturase2 (Fads2) Rs174583 Genetic Variant and Dietary Antioxidant Capacity: Cardio-Metabolic Risk Factors in Obese Individuals. BMC Endocrine Disorders. 2022;22(1):-. |
BibTex | @article{ author = {Khodarahmi M and Javidzade P and Farhangi MA and Hashemzehi A and Kahroba H}, title = {Interplay Between Fatty Acid Desaturase2 (Fads2) Rs174583 Genetic Variant and Dietary Antioxidant Capacity: Cardio-Metabolic Risk Factors in Obese Individuals}, journal = {BMC Endocrine Disorders}, volume = {22}, number = {1}, pages = {-}, year = {2022} } |
RIS | TY - JOUR AU - Khodarahmi M AU - Javidzade P AU - Farhangi MA AU - Hashemzehi A AU - Kahroba H TI - Interplay Between Fatty Acid Desaturase2 (Fads2) Rs174583 Genetic Variant and Dietary Antioxidant Capacity: Cardio-Metabolic Risk Factors in Obese Individuals JO - BMC Endocrine Disorders VL - 22 IS - 1 SP - EP - PY - 2022 ER - |